Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OFATUMUMAB vs OFLOXACIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OFATUMUMAB vs OFLOXACIN: Safety Overview

Metric OFATUMUMAB OFLOXACIN
Total FAERS Reports 29,913 3,062
Deaths Reported 695 198
Death Rate 2.3% 6.5%
Hospitalizations 3,616 1,257
Average Patient Age 47.5 yrs 58.0 yrs
% Female Patients 74.9% 53.5%
FDA Approval Date N/A Apr 12, 2024
Manufacturer Novartis Pharmaceuticals Corporation Cadila Pharmaceuticals Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued